These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28271553)

  • 1. Mechanical circulatory support in patients with severe aortic stenosis and left ventricular dysfunction undergoing percutaneous coronary intervention.
    Alkhouli M; Al Mustafa A; Chaker Z; Alqahtani F; Aljohani S; Holmes DR
    J Card Surg; 2017 Apr; 32(4):245-249. PubMed ID: 28271553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of complex coronary intervention in combination with percutaneous aortic valve implantation in patients with aortic stenosis using percutaneous left ventricular assist device (TandemHeart).
    Piazza N; Serruys PW; de Jaegere P
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):161-6. PubMed ID: 19160444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk left main coronary stenting supported by percutaneous left ventricular assist device.
    Bonvini RF; Hendiri T; Camenzind E; Verin V
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):209-12. PubMed ID: 16152645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of TandemHeart for high-risk tandem procedures: percutaneous balloon aortic valvuloplasty followed by complex PCI.
    Rajdev S; Irani A; Sharma S; Kini A
    J Invasive Cardiol; 2007 Nov; 19(11):E346-9. PubMed ID: 17986736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staged High-Risk Percutaneous Coronary Intervention with Impella Support after On-Pump Transcatheter Aortic Valve Replacement.
    Arora S; Bahekar AA
    Tex Heart Inst J; 2016 Oct; 43(5):423-427. PubMed ID: 27777528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective Mechanical Circulatory Support in the Percutaneous Treatment of Patients With Combined Complex Coronary Artery Disease and Severe Aortic Valve Stenosis.
    Briguori C; Focaccio A; D'Amore C; Selvetella L; Lonobile T
    J Invasive Cardiol; 2019 Mar; 31(3):52-56. PubMed ID: 30819975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Yeoh J; Dworakowski R; Hill J; Byrne J
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):851-854. PubMed ID: 31617327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function].
    Pagnotta PA; Chiarito M; Pllaha E; Mantovani R; Mennuni MG; Rossi ML; Reimers B
    G Ital Cardiol (Rome); 2018 Mar; 19(3):191-193. PubMed ID: 29873647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter aortic valve implantation in patients with LV dysfunction: impact on mortality and predictors of LV function recovery.
    Elhmidi Y; Bleiziffer S; Deutsch MA; Krane M; Mazzitelli D; Lange R; Piazza N
    J Invasive Cardiol; 2014 Mar; 26(3):132-8. PubMed ID: 24610508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of dobutamine stress echocardiography in a patient with aortic valve stenosis and left ventricular dysfunction: a case report].
    Shimizu M; Tatsumi K; Miwa Y; Shima T; Okada T; Minami H; Mukohara N
    J Cardiol; 2004 Feb; 43(2):81-6. PubMed ID: 15017788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
    Thomas JL; Al-Ameri H; Economides C; Shareghi S; Abad DG; Mayeda G; Burstein S; Shavelle DM
    J Invasive Cardiol; 2010 Aug; 22(8):360-4. PubMed ID: 20679671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous aortic valvuloplasty as a bridge to a high-risk percutaneous coronary intervention.
    Aqel RA; Hage FG; Zoghbi GJ
    J Invasive Cardiol; 2007 Aug; 19(8):E238-41. PubMed ID: 17712214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic support using the Impella 2.5 catheter system during high-risk percutaneous coronary intervention in a patient with severe aortic stenosis.
    Harjai KJ; O'Neill WW
    J Interv Cardiol; 2010 Feb; 23(1):66-9. PubMed ID: 20040004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transaortic, video-assisted removal of a mobile left ventricular apical thrombus in a patient with aortic stenosis and severe left ventricular dysfunction.
    Williamson C; Sheehan LB; Venesy DM; D'Agostino RS
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):e1-3. PubMed ID: 26515878
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors affecting left ventricular remodeling after valve replacement for aortic stenosis. An overview.
    Villa E; Troise G; Cirillo M; Brunelli F; Tomba MD; Mhagna Z; Tasca G; Quaini E
    Cardiovasc Ultrasound; 2006 Jun; 4():25. PubMed ID: 16803632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transapical aortic valve implantation off-pump in patients with impaired left ventricular function.
    Van Linden A; Kempfert J; Blumenstein J; Holzhey D; Rastan AJ; Mohr FW; Walther T
    Ann Thorac Surg; 2011 Jul; 92(1):18-23. PubMed ID: 21718826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should I treat a significant and inoperable left main coronary atherosclerotic disease (LMCAD) in the setting of a severely depressed left ventricular systolic function and severe aorto-iliac atherosclerotic disease?
    Ibrahim AW; Preeyanont P; Rab ST; Al-Rashid F; Hildebrandt HA; Kahlert P; Deharo P; Cuisset T
    EuroIntervention; 2015 Sep; 11(5):605-8. PubMed ID: 26390521
    [No Abstract]   [Full Text] [Related]  

  • 20. Early and long-term outcomes after surgical treatment in patients with aortic stenosis and severe left ventricular heart failure without concomitant coronary artery disease with respect to preoperative mean transvalvular pressure gradient.
    Zakrzewski D; Orłowska-Baranowska E; Sitko T; Religa G; Hoffman P; Stepińska J
    Kardiol Pol; 2007 Feb; 65(2):153-7; discussion 158-9. PubMed ID: 17366359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.